Publication:
An ex vivo native environment precision medicine test shows high clinical correlation with responses to first line acute myeloid leukemia treatment

dc.contributor.authorMontesinos, P
dc.contributor.authorBallesteros, J
dc.contributor.authorMartinez Cuadron, D
dc.contributor.authorMartinez Lopez, J
dc.contributor.authorSerrano, J
dc.contributor.authorPerez de Oteyza, J
dc.contributor.authorFernandez, P
dc.contributor.authorRodriguez Macias, G
dc.contributor.authorVidriales, B
dc.contributor.authorHerrera, P
dc.contributor.authorTormo, M
dc.contributor.authorBergua, J
dc.contributor.authorGarcia, R
dc.contributor.authorVives, S
dc.contributor.authorFernandez, MA
dc.contributor.authorLavilla, E
dc.contributor.authorJimenez, S
dc.contributor.authorPerez Simon, JA
dc.contributor.authorSimiele, A
dc.contributor.authorGonzalez, A
dc.contributor.authorGonzalez, B
dc.contributor.authorBurgaleta, C
dc.contributor.authorLopez, JA
dc.contributor.authorBethancourt, C
dc.contributor.authorBautista, G
dc.contributor.authorAlonso, A
dc.contributor.authorColorado, M
dc.contributor.authorSierra, J
dc.contributor.authorNavas, B
dc.contributor.authorHernandez Rivas, JA
dc.contributor.authorVera, JA
dc.contributor.authorAmador, L
dc.contributor.authorCordoba, R
dc.contributor.authorde la Fuente, A
dc.contributor.authorRamos, F
dc.contributor.authorCervero, CJ
dc.contributor.authorRayon, C
dc.contributor.authorSalamero, O
dc.contributor.authorMarti, E
dc.contributor.authorLoez, A
dc.contributor.authorOlave, T
dc.contributor.authorGaspar, M
dc.contributor.authorGorrochategui, J
dc.contributor.authorRojas, JL
dc.contributor.authorGomez, C
dc.contributor.authorHernandez, P
dc.contributor.authorRobles, A
dc.contributor.authorOrtega, I
dc.contributor.authorVilloria, J
dc.contributor.authorMoscardo, F
dc.contributor.authorTroconiz, I
dc.contributor.authorSanz, MA
dc.contributor.authoraffiliation[Montesinos,P; Martinez Cuadron,D; Moscardo,F; Sanz,MA] Hospital Universitari i Politecnic La Fe, Valencia. [Ballesteros,J; Gaspar,G; Gorrochategui,J; Rojas, JL; Gomez,C; Hernandez,P; Robles,A] Vivia Biotech, Tres Cantos. [Martinez Lopez, J] Hospital Universitario 12 de Octubre, Madrid. [Serrano,J] Hospital Universitario Reina Sofia, Cordoba. [Perez de Oteyza,J] Hospital Universitario San Chinarro, Madrid. [Fernandez,P] Hospital General Universitario de Alicante, Alicante. [Rodriguez Macias,G] Hospital Gregorio Marañon, Madrid. [Vidriales,B] Hospital Clinico Universitario de Salamanca, Salamanca. [Herrera,P] Hospital Universitario Ramon y Cajal, Madrid. [Tormo,M] Hospital Clinico Universitario de Valencia, Valencia.[Bergua,J ]Hospital San Pedro de Alcantara, Caceres. [Garcia,R] Hospital Universitario de Castellon, Castellon. [Vives,S] Hospital Universitari Germans Trias i Pujol, Badalona. [Fernandez,MA] Hopsital Xeral Cies, Vigo. [Lavilla,E] Hospital Lucus Augusti, Lugo. [Jimenez,S] Hospital Universitario de Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria. [Perez Simon,JA] Hospital Universitario Virgen del Rocio, Sevilla. [Simiele,A] Hospital Povisa, Vigo. [Gonzalez,A] Hospital Universitario Clinico San Carlos, Madrid. [Gonzalez,B] Hospital Universitario de Canarias, La Laguna. [Burgaleta,C] Hospital Universitario Principe de Asturias, Alcala de Henares. [Lopez, JA] Complejo Hospitalario de Jaen, Jaen. [Bethancourt,C] Hospital Carlos Haya, Malaga. [Bautista,G] Hospital Universitario Puerta de Hierro, Majadahonda. [Alonso,A] Hospital Quiron, Madrid. [Colorado,M] Hospital Universitario Marques de Valdecilla, Santander. [Sierra,J] Hospital de la Santa Creu i Sant Pau, Barcelona. [Navas,B] Hospital Moncloa. [Hernandez Rivas, JA] Hospital Infanta Leonor, Madrid. [Vera,JA] Hospital Universitario Virgen Macarena, Sevilla. [Amador,L] Hospital Montecelo, Pontevedra. [Cordoba,R] Hospital Fundacion JImenez Diaz. [de la Fuente,A] MD Anderson Medical Center, Madrid. [Ramos,F] Hospital Universitario de Leon, Leon. [Cervero,CJ] Hospital Virgen de la Luz, Cuenca. [Rayon,C] Hospital Universitario Central de Asturias, Oviedo. [Salamero,O] Hospital Universitari Vall d’Hebron, Barcelona. [Marti,E] Hospital de Manises, Manises. [Loez,A] Hospital Arnau de Vilanova, Valencia. [Olave,T] Hospital Clinico Universitario LOzano Blesa, Zaragoza. [Ortega,I] Universidad del Pais Vasco, Bilbao. [Villoria,J] Medicxact, Madrid. [Troconiz,I] Universidad de Navarra, Pamplona, Spain.es
dc.date.accessioned2016-10-03T11:14:31Z
dc.date.available2016-10-03T11:14:31Z
dc.date.issued2016-06
dc.description.abstractThis novel test is able to predict the clinical response to Ida+Ara-C induction with overall correlation and predictive values of 80%, higher than ever achieved. Considering this result and current clinical response rate of 66.7% (70% in this study), clear clinical benefits can be achieved with the use of the test. Adding the cytogenetic risk profile further increase the correlation to 90%. Thus this novel test may be valuable information to guide 1st line patient therapyes
dc.description.versionNoes
dc.identifier.citationMontesinos P, Ballesteros J, Martinez Cuadron D. Martinez Lopez J, Serrano J, Perez de Oteyza J et al. An ex vivo native environment precision medicine test shows high clinical correlation with responses to first line acute myeloid leukemia treatment. Haematologica. 2016; 101 (s1) P569es
dc.identifier.essn1592-8721
dc.identifier.issn0390-6078
dc.identifier.urihttp://hdl.handle.net/10668/2442
dc.journal.titleHaematologica
dc.language.isoen
dc.publisherFerrata Storti Foundationes
dc.relation.publisherversionhttp://www.haematologica.org/content/101/s1es
dc.rights.accessRightsopen access
dc.subjectAdultoes
dc.subjectMédula óseaes
dc.subjectCitarabinaes
dc.subjectAmbientees
dc.subjectHumanoses
dc.subjectIdarrubicinaes
dc.subjectQuimioterapia de inducciónes
dc.subjectMantenimientoes
dc.subject.meshMedical Subject Headings::Named Groups::Persons::Age Groups::Adultes
dc.subject.meshMedical Subject Headings::Anatomy::Hemic and Immune Systems::Immune System::Bone Marrowes
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Nucleic Acids, Nucleotides, and Nucleosides::Nucleosides::Pyrimidine Nucleosides::Cytidinees
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Biological Phenomena::Ecological and Environmental Phenomena::Environmentes
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humanses
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons, Cyclic::Hydrocarbons, Aromatic::Polycyclic Hydrocarbons, Aromatic::Naphthacenes::Anthracyclines::Daunorubicin::Idarubicines
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Induction Chemotherapyes
dc.subject.meshMedical Subject Headings::Health Care::Health Care Facilities, Manpower, and Services::Maintenancees
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Remission Inductiones
dc.titleAn ex vivo native environment precision medicine test shows high clinical correlation with responses to first line acute myeloid leukemia treatmentes
dc.typeconference presentation
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
MontesinosP_AnExVivoNative.pdf
Size:
58.83 KB
Format:
Adobe Portable Document Format
Description:
Abstract